Chronic dizziness / Persistent Postural Perceptual Dizziness (PPPD) Signs and Symptoms Dizziness and giddiness
Conditions
Interventions
This is a randomised controlled feasibility trial. It also includes nested qualitative interviews with participants. The objective is to gather preliminary information in preparation for conducting a
Sponsors
King's College London
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Patients attending the neuro-otology balance clinic at St George’s University Hospitals Foundation Trust with symptoms of chronic dizziness (>= 3 months) made worse by movement of the self and/or the environment 2. Dizziness Handicap Inventory (DHI) > = 40 3. Aged > = 18 years 4. Not currently participating in vestibular rehabilitation or psychological treatment (talking therapies) 5. Able to provide consent and willing to comply with the proposed training and testing regime
Exclusion criteria
Exclusion criteria: 1. Patients with incomplete diagnosis or ongoing investigations 2. Patients with vestibular migraine or other headache/migraine disorder with > = 3 headaches a month and/or MIDAS (Migraine Disability Assessment) > = 6 3. Patients with active Meniere’s disease or BPPV (Benign Paroxysmal Positional Vertigo) 4. Patients with central vestibular disorders (excluding migraine and functional disorders), other neurological disorders, significant systematic illness or known psychiatric disorders 5. Patients with acute orthopaedic disorders influencing balance control and gait 6. Insufficient grasp of written/spoken English
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Primary feasibility outcomes collected at the end of the trial: 1. Suitability of eligibility criteria measured by recording the number of people excluded from the trial 2. Willingness to participate measured by the proportion of eligible patients who agree to participate 3. Retention rates measured by the proportion of participants who were randomised that completed follow-up assessment as well as recording of attendance at therapist sessions 4. Time needed to collect and analyse data measured by timesheets 5. Acceptability of the intervention measured at 4 months up using a questionnaire based on the component constructions in the theoretical framework of acceptability | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary feasibility outcomes measured at baseline and 4 months: 1. Dizziness handicap is measured using the Dizziness Handicap Inventory (DHI) 2. Visually induced dizziness is measured using the Visual Vertigo Analogue Scale (VVAS) 3. Dizziness interference is measured using the visual analogue scale (VAS) 4. Health-related quality of life is measured using the European Quality of Life questionnaire EQ5D (EuroQol) 5. Balance is measured using the mini-Balance Evaluation Systems Test (mini-BEStest) Process outcome measures measured at baseline and 4 months: 1. Illness perceptions are measured using the Brief Illness Perception Questionnaire (B-IPQ) 2. Cognitive and behavioural responses to dizziness are measured using the Cognitive and Behavioural Responses to Symptoms Questionnaire (CBRSQ) 3. Anxiety is measured using the Generalised Anxiety Disorders-7 Questionnaire (GAD-7) 4. Depression is measured using the Patient Health Questionnaire-9 (PHQ-9) | — |
Countries
England, United Kingdom
Outcome results
None listed